[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1104970A1 - Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis - Google Patents

Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Info

Publication number
HK1104970A1
HK1104970A1 HK07113348.5A HK07113348A HK1104970A1 HK 1104970 A1 HK1104970 A1 HK 1104970A1 HK 07113348 A HK07113348 A HK 07113348A HK 1104970 A1 HK1104970 A1 HK 1104970A1
Authority
HK
Hong Kong
Prior art keywords
methods
hemoptysis
bronchial
tracheal
alveolar
Prior art date
Application number
HK07113348.5A
Other languages
English (en)
Inventor
Lars Heslet
Lars Otto Uttenthal
Original Assignee
Pharmaorigin Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaorigin Aps filed Critical Pharmaorigin Aps
Publication of HK1104970A1 publication Critical patent/HK1104970A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
HK07113348.5A 2004-09-10 2007-12-06 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis HK1104970A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60875904P 2004-09-10 2004-09-10
US62297704P 2004-10-28 2004-10-28
US69396905P 2005-06-24 2005-06-24
PCT/DK2005/000576 WO2006026998A1 (en) 2004-09-10 2005-09-09 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Publications (1)

Publication Number Publication Date
HK1104970A1 true HK1104970A1 (en) 2008-02-01

Family

ID=35482229

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113348.5A HK1104970A1 (en) 2004-09-10 2007-12-06 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Country Status (13)

Country Link
US (2) US8431535B2 (no)
EP (1) EP1791555B1 (no)
JP (2) JP2008512403A (no)
KR (1) KR101241434B1 (no)
AU (1) AU2005282065B2 (no)
BR (1) BRPI0515163A (no)
CA (1) CA2579884C (no)
DK (1) DK1791555T3 (no)
HK (1) HK1104970A1 (no)
IL (1) IL181824A (no)
MX (1) MX2007002903A (no)
NO (1) NO20071824L (no)
WO (1) WO2006026998A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005282065B2 (en) 2004-09-10 2013-02-07 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
RU2496515C2 (ru) * 2005-06-24 2013-10-27 Драгрекьюэ Апс Введение в дыхательные пути активированного белка с при воспалительных состояниях, поражающих дыхательные пути
US20070225749A1 (en) 2006-02-03 2007-09-27 Martin Brian B Methods and devices for restoring blood flow within blocked vasculature
ES2399138T3 (es) * 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
EP2403583B1 (en) 2009-03-06 2016-10-19 Lazarus Effect, Inc. Retrieval systems
US20120141467A1 (en) * 2010-12-03 2012-06-07 Schneider Daniel J Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
US9301936B2 (en) 2013-07-08 2016-04-05 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations of tranexamic acid and their use
EP3256200A1 (en) 2015-02-11 2017-12-20 Covidien LP Expandable tip medical devices and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920845A (en) 1971-08-03 1975-11-18 Beecham Group Ltd 2-nitroindan-1,3-dione
US5096916A (en) 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5690910A (en) 1995-08-18 1997-11-25 Baker Norton Pharmaceuticals, Inc. Method for treating asthma
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
AU6053698A (en) 1997-01-29 1998-08-18 University Technology Corporation Plasminogen activator as an anti-inflammatory agent
IL138153A0 (en) * 1998-03-16 2001-10-31 Inhale Therapeutic Syst Methods and devices for delivering aerosolized active agents
EP1131055B1 (en) * 1998-11-10 2005-11-09 ALTANA Pharma AG Treatment set containing lungsurfactant compositions
PL365042A1 (en) * 2000-05-10 2004-12-27 Novo Nordisk A/S Pharmaceutical composition comprising a factor viia and a factor xiii
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
WO2003039581A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
DK1474439T3 (da) 2002-02-04 2009-08-03 Salpep Biotechnology Inc Dipeptider og tripeptider med anti-inflammatorisk virkning
MXPA04010560A (es) * 2002-04-25 2005-08-15 Scripps Research Inst Tratamiento y prevencion de condiciones pulmonares.
PT1499719E (pt) * 2002-04-30 2011-02-09 Bayer Healthcare Llc Variantes polipeptídicas do factor vii ou viia
EP1617799A2 (en) 2003-04-09 2006-01-25 Wyeth Hemophilia treatment by inhalation of coagulation factors
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US7404957B2 (en) * 2003-08-29 2008-07-29 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
AU2005282065B2 (en) 2004-09-10 2013-02-07 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Also Published As

Publication number Publication date
JP2012092131A (ja) 2012-05-17
IL181824A (en) 2012-05-31
NO20071824L (no) 2007-04-10
EP1791555B1 (en) 2013-03-13
BRPI0515163A (pt) 2008-07-08
US20070258971A1 (en) 2007-11-08
DK1791555T3 (da) 2013-06-10
KR20070067127A (ko) 2007-06-27
WO2006026998A1 (en) 2006-03-16
AU2005282065A1 (en) 2006-03-16
US7807639B2 (en) 2010-10-05
WO2006026998A8 (en) 2006-05-04
MX2007002903A (es) 2007-07-11
JP2008512403A (ja) 2008-04-24
US20070060517A1 (en) 2007-03-15
KR101241434B1 (ko) 2013-03-12
AU2005282065B2 (en) 2013-02-07
EP1791555A1 (en) 2007-06-06
CA2579884A1 (en) 2006-03-16
CA2579884C (en) 2013-12-31
JP5537537B2 (ja) 2014-07-02
IL181824A0 (en) 2007-07-04
US8431535B2 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
HK1104970A1 (en) Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
SI1458360T1 (sl) Pulmonalno dajanje aminoglikozidov
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
WO2005074913A3 (en) Compositions and methods for treating contracture
TN2009000132A1 (en) Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
MX2009010066A (es) Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer.
WO2006138468A3 (en) Use of vegf for wound healing
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
WO2010006219A3 (en) Use of scaffold comprising fibrin for delivery of stem cells
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
WO2008045559A3 (en) Methods of treating oral mucositis
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
EP2465923A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
PL1778833T3 (pl) Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran
TW200507840A (en) Method of treating multiple myeloma
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
HK1106253A1 (en) Desoxo-nonadepsipeptides
TW200510449A (en) Acylated nonadepsipeptides
SG149875A1 (en) Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
UA85676C2 (en) Carbonyl compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170909